Catalyst
Slingshot members are tracking this event:
The FDA has asked Teva to re-analyze blood levels of certain metabolites in a CRL for SD-809 NDA. Teva will submit its response in Q3
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TEVA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 20, 2016
Occurred Source:
http://www.tevapharm.com/news/teva_announces_fda_acceptance_of_resubmitted_new_drug_application_for_sd_809_for_treatment_of_chorea_associated_with_huntington_disease_10_16.aspx
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sd-809, Deutetrabenazine, Huntington's Disease
